Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment

J Heart Lung Transplant. 2005 Oct;24(10):1489-500. doi: 10.1016/j.healun.2005.03.011. Epub 2005 Jul 27.
No abstract available

Publication types

  • Consensus Development Conference

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage
  • Antithrombin III / antagonists & inhibitors
  • Extracorporeal Membrane Oxygenation*
  • Fluid Therapy
  • Free Radical Scavengers / administration & dosage
  • Humans
  • Lung Diseases / etiology
  • Lung Diseases / therapy*
  • Lung Transplantation / adverse effects*
  • Matrix Metalloproteinases / administration & dosage
  • Nitric Oxide / administration & dosage
  • Platelet Activating Factor / antagonists & inhibitors
  • Postoperative Care
  • Prostaglandins / administration & dosage
  • Pulmonary Surfactants / administration & dosage
  • Receptors, Complement / administration & dosage
  • Reoperation
  • Reperfusion Injury / etiology
  • Reperfusion Injury / therapy*
  • Respiration, Artificial

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Free Radical Scavengers
  • Platelet Activating Factor
  • Prostaglandins
  • Pulmonary Surfactants
  • Receptors, Complement
  • soluble complement inhibitor 1
  • Nitric Oxide
  • Antithrombin III
  • Matrix Metalloproteinases